| S.NO | Socio-demographic characteristics of the study participants | Sub-set | Percentages (%) | Frequency (n) |
| 1 | Education | Primary | 9% | 18 |
| Metric | 20% | 40 | ||
| Intermediate | 17% | 34 | ||
| MBBS/Graduation | 3% | 06 | ||
| Masters | 2% | 04 | ||
| Post graduation/Phd | 49% | 98 | ||
| 2 | Co-morbidities | No comorbidity | 90% | 180 |
| DM | 2% | 04 | ||
| Asthma | 4% | 08 | ||
| HTN | 2% | 04 | ||
| Hepatitis | 2% | 04 | ||
| Ovarian CA | 0% | 00 | ||
| 3 | COVID-19 vaccine status | Vaccination no | 63% | 126 |
| Vaccination yes | 37% | 74 | ||
| 4 | Hepatitus-B vaccine status | Vaccination yes | 93% | 186 |
| Vaccination no | 7% | 14 | ||
| 5 | Seasonal flu vaccine status | Seasonal flu vaccination no | 7% | 14 |
| Seasonal flu vaccination yes | 93% | 186 | ||
| 6 | Blood groups of the study participants | A+ | 7% | 14 |
| A− | 4% | 08 | ||
| B+ | 27% | 54 | ||
| B− | 3% | 06 | ||
| AB+ | 2% | 04 | ||
| AB− | 1% | 02 | ||
| O+ | 1% | 02 | ||
| O− | 1% | 02 | ||
| Unkown | 54% | 108 |